Survival outcome among 54 intubated pediatric bone marrow transplant patients.
OBJECTIVE
To assess the outcome of children who required endotracheal intubation after bone marrow transplantation and to determine whether prognostic indicators that might assist decision-making regarding the institution of mechanical ventilation could be identified.


METHODS
Retrospective chart review.


METHODS
Critical care, reverse isolation unit at a university hospital.


METHODS
Fifty-four pediatric bone marrow transplant recipients who required endotracheal intubation.


METHODS
None.


RESULTS
The following variables were assessed for effect on survival: a) the presence of additional nonhematoporetic organ system failure; b) the duration of required ventilatory assistance; c) the etiology of respiratory failure; d) the presence of significant graft vs. host disease; and e) the underlying disease for which the transplant was done. Six of 54 intubated pediatric bone marrow transplant recipients were extubated and discharged from the hospital. No patient with a diagnosis of leukemia or with multiple organ system failure could be extubated or discharged from the hospital. The presence of pulmonary parenchymal disease indicated poor prognosis for survival.


CONCLUSIONS
The decision to intubate a pediatric bone marrow transplant patient remains a difficult one. In this population, multiple organ system failure and primary pulmonary parenchymal disease were associated with a high mortality rate. These factors should be taken into account before and throughout the course of mechanical ventilation in this patient population.
Todd
K
K
Gwynne Hazen Cherry Memorial Laboratories, Department of Pediatrics, UCLA School of Medicine 90024-1752.
Wiley
F
F
Landaw
E
E
Gajewski
J
J
Bellamy
P E
PE
Harrison
R E
RE
Brill
J E
JE
Feig
S A
SA
D000293:Adolescent; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003422:Critical Care / Q000379:methods*; D005260:Female; D006801:Humans; D007223:Infant; D007442:Intubation, Intratracheal; D008171:Lung Diseases / Q000401:mortality / Q000628:therapy; D008297:Male; D009102:Multiple Organ Failure / Q000401:mortality; D011379:Prognosis; D012121:Respiration, Artificial; D012189:Retrospective Studies; D016896:Treatment Outcome